605016 Stock Overview
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.85 |
| 52 Week High | CN¥23.96 |
| 52 Week Low | CN¥14.54 |
| Beta | 0.53 |
| 1 Month Change | 6.50% |
| 3 Month Change | 9.31% |
| 1 Year Change | -15.95% |
| 3 Year Change | 44.52% |
| 5 Year Change | n/a |
| Change since IPO | 116.07% |
Recent News & Updates
Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Solid Profits Have Weak Fundamentals
Nov 06
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Intrinsic Value Is Potentially 78% Above Its Share Price
Oct 14Many Still Looking Away From Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016)
Sep 29Recent updates
Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Solid Profits Have Weak Fundamentals
Nov 06Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Intrinsic Value Is Potentially 78% Above Its Share Price
Oct 14Many Still Looking Away From Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016)
Sep 29Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors
Aug 23Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes
Jun 26Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be
May 06Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance
May 03If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity
Mar 27Shareholder Returns
| 605016 | CN Food | CN Market | |
|---|---|---|---|
| 7D | 6.4% | -3.0% | -1.2% |
| 1Y | -16.0% | 4.4% | 11.8% |
Return vs Industry: 605016 underperformed the CN Food industry which returned 4.4% over the past year.
Return vs Market: 605016 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 605016 volatility | |
|---|---|
| 605016 Average Weekly Movement | 7.3% |
| Food Industry Average Movement | 7.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 605016 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 605016's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 742 | Hongjian Zhuo | www.sdblcy.com |
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of functional sugar in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto- oligosaccharide, galacto- oligosaccharide, and xylo- oligosaccharide.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Fundamentals Summary
| 605016 fundamental statistics | |
|---|---|
| Market cap | CN¥5.77b |
| Earnings (TTM) | CN¥234.25m |
| Revenue (TTM) | CN¥1.03b |
24.6x
P/E Ratio5.6x
P/S RatioIs 605016 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605016 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.03b |
| Cost of Revenue | CN¥700.55m |
| Gross Profit | CN¥334.31m |
| Other Expenses | CN¥100.06m |
| Earnings | CN¥234.25m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.73 |
| Gross Margin | 32.30% |
| Net Profit Margin | 22.64% |
| Debt/Equity Ratio | 4.3% |
How did 605016 perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield29%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 01:22 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xia Sheng | Citic Securities Co., Ltd. |
| Lin Yang | Guosen Securities Co., Ltd. |
| Wei Liu | Haitong International Research Limited |